Axinix (Axitinib) is a cutting-edge cancer treatment specifically designed to target advanced renal cell carcinoma (kidney cancer). Available in 1mg and 5mg dosages, Axinix works as a tyrosine kinase inhibitor (TKI), blocking the growth and spread of cancer cells by interfering with the proteins responsible for tumour growth and blood vessel development. This targeted therapy provides a powerful, focused approach…
Lenvanix (Lenvatinib) is a powerful cancer-fighting medication available in 10 mg and 4 mg doses. As a targeted therapy, Lenvanix plays a critical role in treating advanced thyroid cancer, liver cancer (hepatocellular carcinoma), and renal cell carcinoma (kidney cancer). This oral medication works by inhibiting proteins in cancer cells that promote tumour growth, helping to slow or even stop the…
Lenvaxen 10 mg (Lenvatinib) is an innovative oral medication designed to treat several types of advanced cancers, including thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). The active ingredient, Lenvatinib, is a multi-targeted tyrosine kinase inhibitor (TKI) that works by blocking the signals that promote the growth of cancer cells and the formation of blood vessels that supply…
Sunitix (Sunitinib) is a powerful oral medication used to treat several types of advanced cancers, including renal cell carcinoma (RCC), gastrointestinal stromal tumours (GIST), and pancreatic neuroendocrine tumours (pNET). Sunitinib, the active ingredient in Sunitix, is a multi-targeted tyrosine kinase inhibitor (TKI) that works by blocking the activity of specific enzymes that promote cancer cell growth and angiogenesis. The process…
